↓ Skip to main content

Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2

Overview of attention for article published in BMC Infectious Diseases, March 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
2 news outlets
twitter
1 X user
wikipedia
1 Wikipedia page
reddit
1 Redditor

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
37 Mendeley